Veterinary Medicine Information website

Biosuis Parvo L (6), süsteemulsioon sigadele

Authorised
  • Leptospira interrogans, serovar Canicola, strain MSLB 1043, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain MSLB 1041, Inactivated
  • Leptospira kirschneri, serovar Grippotyphosa, strain MSLB 1042, Inactivated
  • Leptospira interrogans, serovar Bratislava, strain MSLB 1040, Inactivated
  • Leptospira borgpetersenii, serovar Hardjo, strain MSLB 1039, Inactivated
  • Leptospira interrogans, serovar Pomona, strain MSLB 1037, Inactivated
  • Porcine parvovirus, strain CAPM V198 S-27, Inactivated
Download as PDF

Product identification

Medicine name:
Biosuis Parvo L (6), süsteemulsioon sigadele
Active substance:
  • Leptospira interrogans, serovar Canicola, strain MSLB 1043, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain MSLB 1041, Inactivated
  • Leptospira kirschneri, serovar Grippotyphosa, strain MSLB 1042, Inactivated
  • Leptospira interrogans, serovar Bratislava, strain MSLB 1040, Inactivated
  • Leptospira borgpetersenii, serovar Hardjo, strain MSLB 1039, Inactivated
  • Leptospira interrogans, serovar Pomona, strain MSLB 1037, Inactivated
  • Porcine parvovirus, strain CAPM V198 S-27, Inactivated
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Leptospira interrogans, serovar Canicola, strain MSLB 1043, Inactivated
    51.00
    Antibody microagglutination-lytic reaction
    /
    1.00
    dose
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain MSLB 1041, Inactivated
    51.00
    Antibody microagglutination-lytic reaction
    /
    1.00
    dose
  • Leptospira kirschneri, serovar Grippotyphosa, strain MSLB 1042, Inactivated
    51.00
    Antibody microagglutination-lytic reaction
    /
    1.00
    dose
  • Leptospira interrogans, serovar Bratislava, strain MSLB 1040, Inactivated
    40.00
    Antibody microagglutination-lytic reaction
    /
    1.00
    dose
  • Leptospira borgpetersenii, serovar Hardjo, strain MSLB 1039, Inactivated
    40.00
    Antibody microagglutination-lytic reaction
    /
    1.00
    dose
  • Leptospira interrogans, serovar Pomona, strain MSLB 1037, Inactivated
    32.00
    Antibody microagglutination-lytic reaction
    /
    1.00
    dose
  • Porcine parvovirus, strain CAPM V198 S-27, Inactivated
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AL
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 1560
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 8/01/2026
Download